Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.

@article{Hviid2013UseOS,
  title={Use of selective serotonin reuptake inhibitors during pregnancy and risk of autism.},
  author={Anders Hviid and Mads Melbye and Bj{\"o}rn Pasternak},
  journal={The New England journal of medicine},
  year={2013},
  volume={369 25},
  pages={
          2406-15
        }
}
BACKGROUND Studies have raised concern about an association between the use of selective serotonin reuptake inhibitors (SSRIs) during pregnancy and an increased risk of autism spectrum disorders in the offspring. METHODS We conducted a cohort study of all singleton live births in Denmark from 1996 through 2005 (626,875 births), with follow-up through 2009. Using Danish population registries, we linked information on maternal use of SSRIs before and during pregnancy, autism spectrum disorders… Expand
Risk of autism spectrum disorder in offspring following paternal use of selective serotonin reuptake inhibitors before conception: a population-based cohort study
TLDR
The mildly increased risk of ASD in the offspring associated with paternal SSRIs use before conception may be attributable to paternal underlying psychiatric indications related to SSRI use or other unmeasured confounding factors. Expand
In Utero Exposure to Selective Serotonin Reuptake Inhibitors and Risk for Autism Spectrum Disorder
TLDR
Evidence that in utero exposure to SSRIs increases a child’s risk associated with ASD is found and these results, while adding to the limited knowledge on prenatal pharmacological exposures as potential ASD risk factors, need to be balanced against the benefits of indicated medication use by pregnant mothers. Expand
Gestational Exposure to Selective Serotonin Reuptake Inhibitors and Offspring Psychiatric Disorders: A National Register-Based Study.
TLDR
Prenatal SSRI exposure was associated with increased rates of depression diagnoses in early adolescence but not with ASD or ADHD, and these findings must be balanced against the substantial adverse consequences of untreated maternal depression. Expand
Association Between Maternal Use of SSRI Medications and Autism in Their Children.
TLDR
Examination of pregnancies from 1998 to 2009 in the Quebec Pregnancy/Children Cohort database that resulted in children with autism spectrum disorder (ASD) as the primary outcome concluded that second- or third-trimester exposure to SSRIs was associated with increased risk for ASD. Expand
Association of Selective Serotonin Reuptake Inhibitor Exposure During Pregnancy With Speech, Scholastic, and Motor Disorders in Offspring.
TLDR
Exposure to SSRIs during pregnancy was associated with an increased risk of speech/language disorders in offspring up to early adolescence, and this finding may have implications for understanding associations betweenSSRIs and child development. Expand
Association Between Serotonergic Antidepressant Use During Pregnancy and Autism Spectrum Disorder in Children
TLDR
In children born to mothers receiving public drug coverage in Ontario, Canada, in utero serotonergic antidepressant exposure compared with no exposure was not associated with autism spectrum disorder in the child, and the previously observed association may be explained by other factors. Expand
Safety of Selective Serotonin Reuptake Inhibitors in Pregnancy: A Review of Current Evidence
TLDR
It is recommended that pregnant women exposed to any SSRI in early pregnancy be offered options for prenatal diagnosis through ultrasound examinations and fetal echocardiography to detect the presence of birth defects. Expand
Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children.
TLDR
Use of antidepressants, specifically selective serotonin reuptake inhibitors, during the second and/or third trimester increases the risk of ASD in children, even after considering maternal depression. Expand
Prenatal Antidepressant Use and Risk of Autism Spectrum Disorders in Children.
To the Editor The register-based cohort study by Boukhris et al1 investigating the association between prenatal antidepressant use and risk of autism spectrum disorders (ASD) in the offspring wasExpand
Autism spectrum disorders: weighing the risk of SSRI exposure in pregnancy
TLDR
This study failed to demonstrate that SSRI exposure during pregnancy is safe in terms of child development outcomes, as an increased risk of ASDs cannot be completely ruled out. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 24 REFERENCES
Parental depression, maternal antidepressant use during pregnancy, and risk of autism spectrum disorders: population based case-control study
TLDR
In utero exposure to both SSRIs and non-selective monoamine reuptake inhibitors (tricyclic antidepressants) was associated with an increased risk of autism spectrum disorders, particularly without intellectual disability. Expand
Investigating Outcomes Following the Use of Selective Serotonin Reuptake Inhibitors for Treating Depression in Pregnancy
TLDR
Evidence of associations between prenatal SSRI exposure and adverse pregnancy outcomes are conflicting, there is an urgent need to evaluate how the particular SSRI used, the dose, timing and duration of use, genetics, concomitant medication use, maternal characteristics and underlying maternal illness all interact to alter pregnancy outcomes. Expand
Antidepressant use during pregnancy and childhood autism spectrum disorders.
TLDR
Although the number of children exposed prenatally to selective serotonin reuptake inhibitors in this population was low, results suggest that exposure, especially during the first trimester, may modestly increase the risk of ASD. Expand
Use of antidepressant medications during pregnancy: a multisite study.
TLDR
The finding that nearly 8% of pregnant women were prescribed antidepressants drugs during the years 2004 and 2005 highlights the importance of understanding the effects of these medications on the developing fetus and on the pregnant woman. Expand
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review.
TLDR
The available evidence suggests that SSRIs and other serotonergic/noradrenergic antidepressants should be used with caution during pregnancy, with careful follow-up of infants exposed to these agents in utero. Expand
Neurochemical correlates of autistic disorder: a review of the literature.
TLDR
Overall, serotonin appears to have the most empirical evidence for a role in autism, but this requires further investigation and replication, and there is little support for the notion that a dysfunction of norepinephrine or the endogenous opioids are related to autism. Expand
Fetal serotonin signaling: setting pathways for early childhood development and behavior.
  • T. Oberlander
  • Psychology, Medicine
  • The Journal of adolescent health : official publication of the Society for Adolescent Medicine
  • 2012
TLDR
The developmental consequences of two key influences that alter fetal 5-HT signaling are reviewed: in utero exposure to 5- HT reuptake inhibitor antidepressants, and genetic variations in the5-HT transporter gene (SLC6A4). Expand
Depression and anxiety during pregnancy: A risk factor for obstetric, fetal and neonatal outcome? A critical review of the literature
  • J. Alder, Nadine S Fink, J. Bitzer, I. Hösli, W. Holzgreve
  • Medicine
  • The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians
  • 2007
TLDR
Elevated levels of depression and anxiety symptoms during pregnancy contribute independently of other biomedical risk factors to adverse obstetric, fetal and neonatal outcome, however, conclusions for women with mood or anxiety disorders are limited. Expand
Epidemiology of Pervasive Developmental Disorders
TLDR
There is evidence that the broadening of the concept, the expansion of diagnostic criteria, the development of services, and improved awareness of the condition have played a major role in explaining this increase, although it cannot be ruled out that other factors might have also contributed to that trend. Expand
Validity of Childhood Autism in the Danish Psychiatric Central Register: Findings from a Cohort Sample Born 1990–1999
TLDR
In 499 children diagnosed with childhood autism in the DPCR, the diagnosis could be confirmed in 469 children (94%) and 30 non-confirmed cases were classified by the reviewers as non-autistic cases and the remaining 25 cases were either classified with another ASD diagnosis or the specific diagnosis was not possible to determine. Expand
...
1
2
3
...